HIGHLIGHTS
- who: Rui Cai from the (UNIVERSITY) have published the paper: Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium, in the Journal: (JOURNAL)
- what: The authors aim to assess risk factors of treatment discontinuation of patients on paliperidone palmitate and risperidone microsphere. Patients were more likely to discontinue when drugs were prescribed by GP only (HR = 1.68 Conclusions: This study shows that patients stay significantly longer on treatment when initiated on paliperidone palmitate as compared to risperidone microspheres. Not surprisingly, the study shows . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.